Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Danaher Completes $5.7B Acquisition of Abcam | Contract Pharma

What are you searching for?

Sign in
Breaking News

Danaher Completes $5.7B Acquisition of Abcam

Abcam is a supplier of protein research tools for life sciences based in Cambridge, England.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Danaher Corp., a global life sciences and diagnostics provider based in Washington D.C., has completed its $5.7 billion acquisition of Abcam plc, a supplier of protein research tools for life sciences based in Cambridge, England. 
 
Abcam has become an indirect wholly owned subsidiary of Danaher.  
 
Danaher’s Life Sciences businesses provides tools and technologies to support the advancement of pharmaceuticals and biopharmaceuticals.
 
Danaher’s biotechnology business, Cytiva, is a global provider of technologies and services for researchers and biopharmaceutical producers advance the development, manufacturing, and delivery of therapeutics. including vaccines, biologics, and cell and gene therapies.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics